logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Small metal concept is active against the trend, Zhangyuan Tungsten Industry and Xianglu Tungsten Industry both hit the limit up.

date
09/05/2025
The small metals concept is going against the trend, with the non-ferrous tungsten sector leading the gains. Companies such as Zhongyang Tungsten, Xianglu Tungsten Hit the limit up, while companies like China Tungsten High-Tech, Xiamen Tungsten, Jindu Mining, Anning Share followed the rise.
Latest
9 m ago
Xuhui Holdings: The sales volume of contracts in April was 1.72 billion yuan.
10 m ago
Qiu Tai Technology (01478.HK) sold a total of 33.229 million camera modules in April, an increase of 8.4% compared to the previous month, but a decrease of 20.1% compared to the same period last year.
10 m ago
Hunan Province Occupational Disease Prevention and Treatment Institute: "3-year-old girl diagnosed with thallium poisoning" was a case from last year, but was mistakenly written as "recently" by the editor.
11 m ago
The Ministry of Housing and Urban-Rural Development held a meeting to promote the development of private economy.
12 m ago
Chardan Capital maintains its rating on Mind Medicine (MNMD.US) at buy, with a target price adjusted from $20.00 to $20.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.